UM

Browse/Search Results:  1-10 of 30 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Journal article
Progress in Molecular Biology and Translational Science, 2019
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite  |  View/Download:7/0  |  Submit date:2019/05/08
Regulatory t Cells  Immunotherapy  Cancer  Tumor Necrosis Factor Receptor Type 2  Tumor Necrosis Factor  
The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Suhana Ahmad;  Nor Azrini Azid;  Jennifer C. Boer;  JitKang Lim;  Xin Chen;  Magdalena Plebansk;  Rohimah Mohamud
Favorite  |  View/Download:9/0  |  Submit date:2019/01/14
Allergy  Tnf  Tnfr2  Regulatory t Cells  Tolerogenic Dendritic Cells  
The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4+Foxp3+ regulatory T cells Journal article
Frontiers in Immunology, 2018,Volume: 9,Issue: JUL
Authors:  He T.;  Liu S.;  Chen S.;  Ye J.;  Wu X.;  Bian Z.;  Chen X.
Favorite  |  View/Download:17/0  |  Submit date:2018/11/06
cd4+foxp3+ Regulatory t Cells  P38 Mapk  Proliferation  Tnf Receptor Type Ii  Tumor Necrosis Factor  
TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Shaikh, Faraz;  He, Jiang;  Bhadra, Pratiti;  Chen, Xin;  Siu, Shirley W., I
Favorite  |  View/Download:20/0  |  Submit date:2018/10/30
Tnf Receptor Type Ii  Tnf  Regulatory t Cells  Virtual Screening  Drug Discovery  Mm-pbsa  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite  |  View/Download:10/0  |  Submit date:2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy  
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer Journal article
SCIENCE SIGNALING, 2018,Volume: 11,Issue: 511
Authors:  Nie, Yingjie;  He, Jiang;  Shirota, Hidekazu;  Trivett, Anna L.;  Yang, De;  Klinman, Dennis M.;  Oppenheim, Joost J.;  Chen, Xin
Favorite  |  View/Download:15/0  |  Submit date:2018/10/30
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics Journal article
FRONTIERS IN PHARMACOLOGY, 2017,Volume: 8
Authors:  Li, Ping;  Zheng, Ying;  Chen, Xin
Favorite  |  View/Download:14/0  |  Submit date:2018/10/30
Tumor Necrosis Factor Alpha (Tnf)  Autoimmune Inflammatory Diseases  Non-steroidal Anti-inflammatory Drugs (Nsaids)  Anti-tnf Biologics  Tnf Receptor  
Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer Journal article
SCIENCE SIGNALING, 2017,Volume: 10,Issue: 462
Authors:  Chen, Xin;  Oppenheim, Joost J.
Favorite  |  View/Download:12/0  |  Submit date:2018/10/30
Corrigendum: TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis Journal article
SCIENTIFIC REPORTS, 2016,Volume: 6
Authors:  Xin Chen,;  Yingjie Nie;  Haitao Xiao;  Zhaoxiang Bian;  Anthony J. Scarzello;  Na-Young Song;  Anna L. Trivett;  De Yang;  Joost J. Oppenheim
Favorite  |  View/Download:2/0  |  Submit date:2019/01/14
TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis Journal article
Scientific Reports, 2016,Volume: 6
Authors:  Chen X.;  Nie Y.;  Xiao H.;  Bian Z.;  Scarzello A.J.;  Song N.-Y.;  Anna T.L.;  Yang D.;  Oppenheim J.J.
Favorite  |  View/Download:6/0  |  Submit date:2018/11/06